RAMKENZA — 2504752
Application number
2504752
Type(s)
Standard Characters
Category
Trademark
CIPO Status
FORMALIZED
TM5 status
LIVE/APPLICATION/
Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
Filed
2026-10-01
Applicant
JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
UNITED STATES OF AMERICA
Agent
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREET
OTTAWA
ONTARIO K1P1C3
Documents
Index headings
- RAMKENZA
Goods (Nice class & Statement)
- 5
- (1) Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, multiple sclerosis, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; Human pharmaceutical preparations for the prevention and treatment of hemolytic disease of the newborn; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, namely, antibacterials and antifungals, anti-allergic medications; human pharmaceutical preparations for the relief of pain
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2026-10-01 | ||
| Created | 2026-10-01 | ||
| Formalized | 2026-10-01 |